Eluracat RSS Authorised This medicine is authorised for use in the European Union capromorelin tartrate Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Eluracat Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Eluracat Active substance capromorelin tartrate International non-proprietary name (INN) or common name capromorelin tartrate Pharmacotherapeutic groupAnterior pituitary lobe hormones and analogues Authorisation details EMA product number EMEA/V/C/005948 Assessment history Expand section Collapse section Changes since initial authorisation of medicine CVMP post-authorisation summary of positive opinion for Eluracat (VRA-0002-G)Adopted Reference Number: EMA/CVMP/446484/2024 English (EN) (139.16 KB - PDF)First published: 11/10/2024 View Initial marketing authorisation documents CVMP summary of positive opinion for EluracatAdopted Reference Number: EMA/CVMP/194243/2023 English (EN) (129.4 KB - PDF)First published: 22/05/2023 View News on Eluracat Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-17 July 202518/07/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 October 202411/10/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 202419/07/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 202322/05/2023 This page was last updated on 23/05/2024 Share this page